focus -WSS

focus

author：comprehensive 2025-09-30 17:45:40 - browse：8

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： How to make over

knowledge

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

FDA rejects Alnylam's heart disease treatment over insufficient data

CDC says it’s too soon to assess risk posed by Covid subvariant

Phenylephrine and the overlooked value of the placebo effect

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

knowledge

focus

Wikipedia

How one medical school became remarkably diverse

People can get long Covid without testing positive for virus: Study

What does generative AI mean for health care? We asked experts

Vivek Ramaswamy made waves in the debate, much as in biotech

In Memoriam: Notable people who died in 2023

Kellogg’s is going to war over Mexico’s nutrition label rules

ChatGPT in medicine: STAT answers readers' burning questions

Wegovy improves function in certain heart failure patients

Medicare details structure of new drug price negotiation program

Vivek Ramaswamy made waves in the debate, much as in biotech

knowledge

FDA authorizes Novavax’s updated Covid

How to make over

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Colorectal cancer study finds potential in overlooked immune cell

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Intellia plays down concerns on accidental germline transmission

knowledge

explore

explore

hotspot